Aberrant activation of the EDN1 axis is now generally considered a common mechanism underlying the progression of various solid tumours, including ovarian, prostate, colon, breast, bladder, and lung cancers, which is an important adverse factor affecting the prognosis [43, 44, 45]. The gene discussed is EDN1; the disease is lung carcinoma.